1.32 USD
+0.65
96.72%
Updated Nov 14, 12:12 PM EST
1 day
96.72%
5 days
58.46%
1 month
29.41%
3 months
-11.41%
6 months
-62.50%
Year to date
-92.33%
1 year
-92.50%
5 years
-99.97%
10 years
-99.97%
 

About: Akanda Corp is a cannabis cultivation, manufacturing, and distribution company. The Company has three reportable segments: Cultivation, Distribution, and Corporate. Cultivating activities comprise the cultivation segment made up of the medical cannabis cultivation operations at RPK/Holigen in Portugal, and medical cannabis cultivation activities. Distributing activities relate to the distribution of medical cannabis by Canmart Ltd in the United Kingdom. Corporate activities entail head office costs and other general corporate expenses related to the administration of the broader group.

Employees: 5

0
Funds holding %
of 6,759 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

1.5% less ownership

Funds ownership: 2.24% [Q1] → 0.74% (-1.5%) [Q2]

50% less funds holding

Funds holding: 4 [Q1] → 2 (-2) [Q2]

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

53% less capital invested

Capital invested by funds: $22.4K [Q1] → $10.6K (-$11.8K) [Q2]

Research analyst outlook

We haven’t received any recent analyst ratings for AKAN.

Financial journalist opinion

Neutral
Newsfile Corp
1 month ago
Akanda Corp. Announces Closing of Underwritten Public Offering
London, United Kingdom--(Newsfile Corp. - October 4, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, entered into an underwriting agreement (the "Underwriting Agreement") with Univest Securities, LLC ("Univest") as the underwriter in connection with the issuance and sale by the Company in an underwritten public offering (the "Offering") of 258,940 of the Company's Common Shares, no par value per share (the "Common Shares" and, such number of Common Shares issued and sold in the Offering, the "Offered Shares"), at a purchase price of $1.00 per Offered Share, and 1,241,060 pre-funded warrants to purchase 1,241,060 Common Shares at a purchase price of each pre-funded warrant equal to the price at which one Common Share is sold in the Offering, minus $0.0001, and the exercise price of each pre-funded warrant is $0.0001 per share (the "Pre-Funded Warrants" and, such number of Pre-Funded Warrants issued and sold in the Offering, the "Offered Pre-Funded Warrants"), pursuant to the Company's effective registration statement on Form F-1 (File No. 333-281945) and a related preliminary prospectus, together with the related final prospectus dated as of October 2, 2024 (such registration statement, preliminary prospectus and the final prospectus, collectively, the "Registration Statement"), filed with the Securities and Exchange Commission.
Akanda Corp. Announces Closing of Underwritten Public Offering
Charts implemented using Lightweight Charts™